Membership in CardioAlianza
LAL-D Patient Organization Joins CardioAlianza On May 20, 2026, during the General Assembly of CardioAlianza held in Valencia, the incorporation of LAL-D Patient Organization as a new member entity was officially approved. We would like to express our sincere...
LAL-D: much more than a rare disease
A new publication in Hepatology International provides important evidence about the role of lysosomal acid lipase (LAL) in liver disease progression. The study shows that lower LAL activity is associated with: 👉 Increased liver inflammation 👉 Greater fibrosis...
“Accede Público Digital” Project
The National Federation of Liver Patients and Transplant Recipients (FNETH), part of COCEMFE, is running in 2026 the project “Accede Público Digital” to support people with disabilities—especially physical and/or organic disabilities—who want to explore or prepare for...
LAL‑D Study – Phase 3
LAL‑D Study – Phase 3 the University of Rochester (USA) is currently conducting Phase 3 of its research project on Lysosomal Acid Lipase Deficiency (LAL‑D). Our organization is not conducting this study, but we would like to help share this opportunity and...
